Taro Pharmaceutical IndusTARO
13F holders, Q1 2025 (March 31)1holders −2
0new positions
2sold out
$42.97avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Taro Pharmaceutical Indus (TARO) in their 13F filings, down 2 from Q4 2024. 0 opened new positions and 2 sold out. The largest holder was MassMutual Private Wealth & Trust, FSB ($3K).
- Company
- Taro Pharmaceutical Indus
- CUSIP
- M8737E108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 170 shares sold, net −170 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| MassMutual Private Wealth & Trust, FSB | 0.00% | No change | 76 | $3K |
"% of holder's portfolio" is TARO's weight in each manager's 13F, not the share of Taro Pharmaceutical Indus the manager owns.